Sungen Laboratories (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Months 9 Days
About Sungen Laboratories (India)
Sungen Laboratories (India) Private Limited (SLIPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 May 2024 ( eight months 9 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Paper Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Thirumal Pathini, Parveda Rao, Vamshi Biroj, and Two other members serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U21000TS2024PTC186080
-
Company No.
186080
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 May 2024
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sungen Laboratories (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Thirumal Pathini
|
Managing Director | 30-May-2024 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Parveda Rao
|
Director | 14-Oct-2024 | Current |
|
Vamshi Biroj
|
Director | 30-May-2024 | Current |
|
Banoth Kalyani
|
Director | 30-May-2024 | Current |
|
Sweta Nandagiri
|
Director | 30-May-2024 | Current |
Financial Performance of Sungen Laboratories (India).
Enhance accessibility to Sungen Laboratories (India)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sungen Laboratories (India)?
Unlock access to Sungen Laboratories (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Aranox Laboratories Private LimitedThirumal Pathini is a mutual person
-
Aranox Pharma Private Limited
Thirumal Pathini is a mutual person
-
Araha Ent Speciality Hospital Llp
Vamshi Biroj is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sungen Laboratories (India)?
Unlock and access historical data on people associated with Sungen Laboratories (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sungen Laboratories (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sungen Laboratories (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
